Package 68071-5165-6

{"route": ["ORAL"], "spl_id": "1b565e10-f520-1a35-e063-6294a90ae2e2", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0368071516562"], "unii": ["0H73WJJ391"], "rxcui": ["151226"], "spl_set_id": ["9ddb8451-a455-87ec-e053-2995a90a5e5e"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["NuCare Pharmaceuticals,Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (68071-5165-6)", "package_ndc": "68071-5165-6", "marketing_start_date": "20200205"}], "brand_name": "Topiramate", "product_id": "68071-5165_1b565e10-f520-1a35-e063-6294a90ae2e2", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68071-5165", "generic_name": "Topiramate", "labeler_name": "NuCare Pharmaceuticals,Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "50 mg/1"}], "application_number": "ANDA090278", "marketing_category": "ANDA", "marketing_start_date": "20141215", "listing_expiration_date": "20261231"}